| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Laboratory of Central Nervous System Studies (Drs. Brown and Gajdusek), NINCDS, National Institutes of Health, Bethesda, MD; the Service de Neurologie (Drs. Cathala and Castaigne), Hôpital de la Salpêtrière, Paris, France; and the Biometry and Field Studies Branch (Dr. Raubertas), NINCDS, National Institutes of Health, Bethesda, MD.
During the 15-year period 1968–1982, a total of 329 patients dying of Creutzfeldt-Jakob disease (CJD) were identified in continental France. Annual mortality rates stabilized at 0.5 to 0.6 cases per million (1.1 to 1.2 cases per million in Paris). Six percent of cases were familial. Although the frequency of CJD was related to population density, no contacts could be established among the great majority of patients. No association with socioeconomic factors, preceding trauma or surgery (excepting one iatrogenic neurosurgical case), or exposure to animal sources of infection was identified. Evidence from this and other epidemiologic studies suggests that CJD is a minimally contagious disease that may be principally acquired in early life from presymptomatic patients, asymptomatic carriers, or chance contamination by environmental sources. It is possible that CJD could also occur sporadically as a noncontagious disease by a mechanism akin to oncogenes in carcinogenesis.
Address correspondence and reprint requests to Dr. Brown, Building 36, Room 5B21, NINCDS, NIH, Bethesda, MD 20892.
Received January 22, 1987. Accepted for publication in final form March 31, 1987.
This article has been cited by other articles:
|
|
 |
|
  A. Aguzzi and A. M. Calella Prions: Protein Aggregation and Infectious Diseases Physiol Rev, October 1, 2009; 89(4): 1105 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Klug, H. Wand, A. Boyd, M. Law, S. Whyte, J. Kaldor, C. L. Masters, and S. Collins Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster Brain, February 1, 2009; 132(2): 493 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Collinge Lessons of kuru research: background to recent studies with some personal reflections Phil Trans R Soc B, November 27, 2008; 363(1510): 3689 - 3696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D.F Wadsworth, S. Joiner, J. M Linehan, E. A Asante, S. Brandner, and J. Collinge The origin of the prion agent of kuru: molecular and biological strain typing Phil Trans R Soc B, November 27, 2008; 363(1510): 3747 - 3753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Brandner, J. Whitfield, K. Boone, A. Puwa, C. O'Malley, J. M Linehan, S. Joiner, F. Scaravilli, I. Calder, M. P. Alpers, et al. Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease Phil Trans R Soc B, November 27, 2008; 363(1510): 3755 - 3763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. F. Wadsworth, S. Joiner, J. M. Linehan, M. Desbruslais, K. Fox, S. Cooper, S. Cronier, E. A. Asante, S. Mead, S. Brandner, et al. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice PNAS, March 11, 2008; 105(10): 3885 - 3890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. F. Wadsworth, S. Joiner, J. M. Linehan, S. Cooper, C. Powell, G. Mallinson, J. Buckell, I. Gowland, E. A. Asante, H. Budka, et al. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein Brain, June 1, 2006; 129(6): 1557 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Schramm, C. J. Johnson, N. E. Mathews, D. McKenzie, J. M. Aiken, and J. A. Pedersen Potential Role of Soil in the Transmission of Prion Disease Reviews in Mineralogy and Geochemistry, January 1, 2006; 64(1): 135 - 152. [Full Text] [PDF]
|
|
|
|
 |
|
 J Collinge Molecular neurology of prion disease J. Neurol. Neurosurg. Psychiatry, July 1, 2005; 76(7): 906 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pocchiari, M. Puopolo, E. A. Croes, H. Budka, E. Gelpi, S. Collins, V. Lewis, T. Sutcliffe, A. Guilivi, N. Delasnerie-Laupretre, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies Brain, October 1, 2004; 127(10): 2348 - 2359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Z Amin, L Smith, P J Luthert, M E Cheetham, and R J Buckley Minimising the risk of prion transmission by contact tonometry Br J Ophthalmol, November 1, 2003; 87(11): 1360 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R Trevitt and P. N Singh Variant Creutzfeldt-Jakob disease: pathology, epidemiology, and public health implications Am. J. Clinical Nutrition, September 1, 2003; 78(3): 651S - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Wadsworth, A. F Hill, J. A Beck, and J. Collinge Molecular and clinical classification of human prion disease Br. Med. Bull., June 1, 2003; 66(1): 241 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Hill, S. Joiner, J. D. F. Wadsworth, K. C. L. Sidle, J. E. Bell, H. Budka, J. W. Ironside, and J. Collinge Molecular classification of sporadic Creutzfeldt-Jakob disease Brain, June 1, 2003; 126(6): 1333 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Collins, A. Boyd, J. S. Lee, V. Lewis, A. Fletcher, C. A. McLean, M. Law, J. Kaldor, M. J. Smith, and C. L. Masters Creutzfeldt-Jakob disease in Australia 1970-1999 Neurology, November 12, 2002; 59(9): 1365 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M A Ferguson-Smith and H. Grant BSE and variant CJD BMJ, June 23, 2001; 322(7301): 1544 - 1544. [Full Text]
|
|
|
|
 |
|
 C. E. M. Hillier and R. L. Salmon Is there evidence for exogenous risk factors in the aetiology and spread of Creutzfeldt-Jakob disease? QJM, September 1, 2000; 93(9): 617 - 631. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tan, M. A. Williams, M. K. Khan, H. C. Champion, N. H. Nielsen, and for the Council on Scientific Affairs, American Me Risk of Transmission of Bovine Spongiform Encephalopathy to Humans in the United States: Report of the Council on Scientific Affairs JAMA, June 23, 1999; 281(24): 2330 - 2339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Brown and R. Bradley 1755 and all that: a historical primer of transmissible spongiform encephalopathy BMJ, December 19, 1998; 317(7174): 1688 - 1692. [Full Text]
|
|
|
|
|
|
S. B. Prusiner Prions PNAS, November 10, 1998; 95(23): 13363 - 13383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Bigelow, M. D. Eisen, D. M. Yen, S. C. Saull, D. Solomon, and D. E. Schmidt Otolaryngological Manifestations of Creutzfeldt-Jakob Disease Arch Otolaryngol Head Neck Surg, June 1, 1998; 124(6): 707 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Prusiner Prion Diseases and the BSE Crisis Science, October 10, 1997; 278(5336): 245 - 251. [Abstract] [Full Text]
|
|
|
|
|
|
S N Cousens, M Zeidler, T F Esmonde, R De Silva, J W Wilesmith, P G Smith, and R G Will Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96 BMJ, August 16, 1997; 315(7105): 389 - 395. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. K. Shetty and R. W. Steele Commentary Review: Prion Diseases Clinical Pediatrics, January 1, 1997; 36(1): 1 - 7. [PDF]
|
|
|
|
 |
|
 S.B. Prusiner Molecular Biology and Genetics of Prion Diseases Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 473 - 493. [Abstract] [PDF]
|
|
|
|
|
|
J.W. Ironside, K. Sutherland, J.E. Bell, L. McCardle, C. Barrie, K. Estebeiro, M. Zeidler, and R.G. Will A New Variant of Creutzfeldt-Jakob Disease: Neuropathological and Clinical Features Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 523 - 530. [Abstract] [PDF]
|
|
|
|
|
|
R M Ridley and H F Baker The myth of maternal transmission of spongiform encephalopathy BMJ, October 21, 1995; 311(7012): 1071 - 1075. [Full Text]
|
|
|
|
 |
|
 D Westaway, V Zuliani, C M Cooper, M Da Costa, S Neuman, A L Jenny, L Detwiler, and S B Prusiner Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes & Dev., April 15, 1994; 8(8): 959 - 969. [Abstract] [PDF]
|
|
|
|
 |
|
 S. B. Prusiner Genetic and Infectious Prion Diseases Arch Neurol, November 1, 1993; 50(11): 1129 - 1153. [Abstract] [PDF]
|
|
|
|
 |
|
 W. A. Woolery Creutzfeldt-Jakob disease in a nursing home resident American Journal of Alzheimer's Disease and Other Dementias, September 1, 1993; 8(5): 5 - 7. [Abstract] [PDF]
|
|
|
|
|
|
J. E. Fradkin, L. B. Schonberger, J. L. Mills, W. J. Gunn, J. M. Piper, D. K. Wysowski, R. Thomson, S. Durako, and P. Brown Creutzfeldt-Jakob Disease in Pituitary Growth Hormone Recipients in the United States JAMA, February 20, 1991; 265(7): 880 - 884. [Abstract] [PDF]
|
|
|
|
 |
|
 W. A. Marks, R. M. Shuman, R. W. Leech, and R. A. Brumback Cerebral Degenerations Producing Dementia: Importance of Neuropathologic Confirmation of Clinical Diagnoses J Geriatr Psychiatry Neurol, October 1, 1988; 1(4): 187 - 198. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
